Not directly related to RAC or oncology, however, I found this YouTube video provides an interesting insight and take on the US Big Pharma industry and the associated politics.
Katie Porter goes megaviral with MUST-SEE takedown during hearing - YouTube
My take-aways:
- plenty of cash to spend on non R&D activities, eg Dividends and stock buy-backs
- Big Pharma will need the potential of the R&D coming out of the likes of RAC to maintain their revenues to continue their spending
- When the time comes, Big Pharma should not have any problem writing big M&A cheques for innovative and game changing IP
Industry news, page-3
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.22 |
Change
0.030(2.52%) |
Mkt cap ! $202.7M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.22 | $1.16 | $78.70K | 66.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 4561 | 1 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.19 |
Change
0.030 ( 0.42 %) |
||||
| Open | High | Low | Volume | ||
| $1.19 | $1.22 | $1.16 | 11297 | ||
| Last updated 15.56pm 07/05/2024 ? | |||||
| RAC (ASX) Chart |